Physician profile

Roopa Samant

Family Medicine · Little Rock, AR

NPI 1124289764

$653.28

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pfizer INC. $114.20 2019
Astellas Pharma US INC $100.92 2019
Merck Sharp & Dohme LLC $72.85 2019-2020
Allergan, INC. $57.73 2019
Amgen INC. $57.32 2019-2020
Horizon Therapeutics Plc $37.84 2019-2020
Astrazeneca Pharmaceuticals Lp $34.41 2019
Takeda Pharmaceuticals U.S.A., INC. $29.63 2019
Sanofi Pasteur INC. $24.84 2019-2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $22.99 2019
Boston Scientific Corporation $16.65 2020
Boehringer Ingelheim Pharmaceuticals, INC. $15.75 2019
Biogen, INC. $15.08 2019
Nevro Corp. $14.78 2022
Amneal Pharmaceuticals LLC $14.46 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $12.85 2019
Shire North American Group INC $10.98 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Roopa Samant

$653.28

in general payments reported 2019-2025

Years
2019-2022
Top company
Pfizer INC.

https://glasscript.com/doctor/395169/roopa-samant

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.